[6-K] Haoxin Holdings Ltd Current Report (Foreign Issuer)
Rhea-AI Filing Summary
Haoxin Holdings Limited reported that it received a notice from Nasdaq on December 15, 2025 stating that the company is not in compliance with the Nasdaq Capital Market’s minimum bid price requirement of US$1.00 per share for continued listing under Listing Rule 5550(a)(2). This means the company’s share price has fallen below the required threshold, putting its Nasdaq listing status at risk if compliance is not restored.
The update was disclosed through a press release dated December 17, 2025, which is attached as an exhibit to the report.
Positive
- None.
Negative
- None.
Insights
Nasdaq minimum bid-price noncompliance introduces delisting risk for Haoxin Holdings.
Haoxin Holdings Limited disclosed that Nasdaq notified the company on December 15, 2025 that it is not in compliance with the minimum bid price requirement of US$1.00 per share for continued listing on the Nasdaq Capital Market under Listing Rule 5550(a)(2). This indicates the stock has traded below the required threshold for the period defined by Nasdaq’s rules.
Such a notice typically begins a defined cure period during which the company must regain compliance, though specific timelines and methods are not detailed in this excerpt. If compliance is not regained within Nasdaq’s allowed period or through any corporate actions permitted by the rules, the company could ultimately face delisting from the Nasdaq Capital Market.
For investors, the key implication is the introduction of listing-status uncertainty, which can affect trading liquidity and broaden or restrict access for certain institutional investors. Further detail on any cure plans or timelines would be found in the referenced press release dated December 17, 2025 or in subsequent disclosures.